1-11 of 11
Chiara Ghiggi
Close
Sort by
Journal Articles

The Addition of Romidepsin to CHOEP and High-Dose Chemotherapy Plus Stem Cell Transplantation Did Not Ameliorate the Outcome of Untreated Angioimmunoblastic T-Cell or Follicular T-Helper Lymphoma: Subgroup Analysis of Phase II FIL-PTCL13 Study

Annalisa Chiappella, Anna Dodero, Andrea Evangelista, Alessandro Re, Lorella Orsucci, Sara Veronica Usai, Claudia Castellino, Vittorio Stefoni, Antonio Pinto, Manuela Zanni, Rosanna Ciancia, Chiara Ghiggi, Francesca Gaia Rossi, Annalisa Arcari, Fiorella Ilariucci, Vittorio Ruggero Zilioli, Leonardo Flenghi, Melania Celli, Stefano Volpetti, Fabio Benedetti, Filippo Ballerini, Gerardo Musuraca, Riccardo Bruna, Caterina Patti, Francesco Leonardi, Luca Arcaini, Massimo Magagnoli, Federica Cavallo, Valentina Tabanelli, Giovannino Ciccone, Stefano A Pileri, Paolo Corradini
Journal: Blood
Blood (2022) 140 (Supplement 1): 6538–6539.
https://doi.org/10.1182/blood-2022-163824
Published: 2022
Journal Articles

Total Metabolic Tumor Volume Is Confirmed As Independent Prognostic Factor in Treatment Naïve Follicular Lymphoma Patients and Can be Combined with FLIPI2 to Improve Prognostic Accuracy. a FOLL12 Substudy By the Fondazione Italiana Linfomi

Stefano Luminari, Luca Guerra, Carla Minoia, Stephane Chauvie, Antonella Anastasia, Federica Cavallo, Paolo Corradini, Sara Rattotti, Rexhep Durmo, Chiara Ghiggi, Jacopo Olivieri, Simone Ferrero, Gloria Margiotta Casaluci, Luca Nassi, Caterina Stelitano, Francesca Ricci, Vittorio Ruggero Zilioli, Antonio Pinto, Manuela Zanni, Bolis Silvia, Caterina Patti, Michele Merli, Annalisa Chiarenza, Gerardo Musuraca, Patrizia Tosi, Massimo Federico, Annibale Versari
Journal: Blood
Blood (2022) 140 (Supplement 1): 1313–1315.
https://doi.org/10.1182/blood-2022-166225
Published: 2022
Journal Articles

Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphoma

Clinical Trials & Observations
Simone Ferrero, Daniele Grimaldi, Elisa Genuardi, Daniela Drandi, Gian Maria Zaccaria, Beatrice Alessandria, Marco Ghislieri, Martina Ferrante, Andrea Evangelista, Barbara Mantoan, Gabriele De Luca, Piero Maria Stefani, Fabio Benedetti, Ivana Casaroli, Manuela Zanni, Claudia Castellino, Vincenzo Pavone, Mario Petrini, Francesca Re, Stefan Hohaus, Gerardo Musuraca, Nicola Cascavilla, Chiara Ghiggi, Anna Marina Liberati, Sergio Cortelazzo, Marco Ladetto
Journal: Blood
Blood (2022) 140 (12): 1378–1389.
https://doi.org/10.1182/blood.2021014270
Published: 2022
Includes: Supplemental data
Journal Articles

Adding Romidepsin to CHOEP in First Line Treatment of Peripheral T-Cell Lymphomas Does Not Improve the Response Rate: Final Analysis of Phase II PTCL13 Study

Annalisa Chiappella, Cristiana Carniti, Alessandro Re, Claudia Castellino, Andrea Evangelista, Valentina Tabanelli, Rosanna Ciancia, Lorella Orsucci, Antonello Pinto, Sara Veronica Usai, Annalisa Arcari, Fiorella Ilariucci, Francesca Gaia Rossi, Fabio Benedetti, Leonardo Flenghi, Chiara Ghiggi, Anna Lia Molinari, Vittorio Stefoni, Stefano Volpetti, Vittorio Ruggero Zilioli, Filippo Ballerini, Riccardo Bruna, Federica Cavallo, Gerardo Musuraca, Caterina Patti, Francesca Re, Monica Tani, Marzia Varettoni, Manuela Zanni, Anna Dodero, Stefano A Pileri, Giovannino Ciccone, Paolo Corradini
Journal: Blood
Blood (2021) 138 (Supplement 1): 134.
https://doi.org/10.1182/blood-2021-153680
Published: 2021
Journal Articles

Rituximab Plus Bendamustine and Cytarabine (R-BAC) in Elderly Patients with Newly Diagnosed Mantle Cell Lymphoma: Long Term Follow-up and Mrd Results of a Phase 2 Study from the Fondazione Italiana Linfomi

Maria Chiara Tisi, Luca Nassi, Caterina Patti, Michele Spina, Simone Ferrero, Monica Tani, Barbara Botto, Anna Lia Molinari, Benedetta Puccini, Emanuele Cencini, Alice Di Rocco, Claudio Chini, Chiara Ghiggi, Renato Zambello, Manuela Zanni, Roberta Sciarra, Martina Ferrante, Caterina Stelitano, Alessandro Re, Stefano Volpetti, Vittorio Ruggero Zilioli, Annalisa Arcari, Francesco Merli, Carlo Visco
Journal: Blood
Blood (2021) 138 (Supplement 1): 384.
https://doi.org/10.1182/blood-2021-153364
Published: 2021
Journal Articles

High Predictive Value of Pre Transplant Minimal Residual Disease Assessment By Combining WT1 Expression and Flow Cytometry in Acute Myeloid Leukemia

Fabio Guolo, MD, Federica Galaverna, MD, Paola Minetto, MD, Livia Giannoni, MD, Chiara Ghiggi, PhD, Marino Clavio, MD, Carmen Di Grazia, MD, Anna Maria Raiola, MD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Adalberto Ibatici, MD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD, Andrea Bacigalupo, MD
Journal: Blood
Blood (2015) 126 (23): 2029.
https://doi.org/10.1182/blood.V126.23.2029.2029
Published: 2015
Journal Articles

The Prognostic Relevance of Comprehensive Risk Score Is Modulated By Therapy: Analysis of 292 Acute Myeloid Leukemia Patients Registered at the Genova Acute Leukemia Registry (REGAL)

Fabio Guolo, MD, Paola Minetto, MD, Elena Clavio, Giordana Pastori, MD, Daniela Guardo, MD, Lisette Del Corso, MD, Chiara Ghiggi, PhD, Maurizio Miglino, PhD, Germana Beltrami, MD, Angelo Michele Carella, Roberto Massimo Lemoli, MD, Andrea Bacigalupo, MD, Marco Gobbi, MD, Marino Clavio, MD
Journal: Blood
Blood (2015) 126 (23): 4885.
https://doi.org/10.1182/blood.V126.23.4885.4885
Published: 2015
Journal Articles

Prognostic Value of Minimal Residual Disease Assessed By WT1 Expression Level and Flow Cytometry in Acute Myeloid Leukemia Patients Undergoing Allogeneic Marrow Transplantation

Livia Giannoni, MD, Fabio Guolo, MD, Paola Minetto, MD, Federica Galaverna, MD, Chiara Ghiggi, MD, Marino Clavio, MD, Samuele Bagnasco, MD, Carmen Di Grazia, MD, Raffaella Grasso, PhD, Nicoletta Colombo, PhD, Daniele Avenoso, MD, Giordana Pastori, MD, Filippo Ballerini, MD, Annalisa Kunkl, PhD, Maurizio Miglino, PhD, Roberto Lemoli, MD, Marco Gobbi, MD, Andrea Bacigalupo, MD
Journal: Blood
Blood (2014) 124 (21): 1027.
https://doi.org/10.1182/blood.V124.21.1027.1027
Published: 2014
Journal Articles

Interferon-Alpha (IFN-a) Is Able To Maintain Complete Molecular Response (CMR) In Chronic Myeloid Leukemia (CML) Patients Who Maintain Undetectable disease After Imatinib (IM) Discontinuation

Angelo Michele Carella, MD, Germana Beltrami, MD, Chiara Ghiggi, MD
Journal: Blood
Blood (2013) 122 (21): 5195.
https://doi.org/10.1182/blood.V122.21.5195.5195
Published: 2013
Journal Articles

Detection of an Unbalanced Ratio Between WT1 Isoforms in Acute Myeloid Leukemia and Its Correlation with Molecular Abnormalities.

Chiara Calabrese, PhD, Gian Matteo Pica, MD, Enrico Bracco, PhD, Anna Serra, PhD, Francesca Carnuccio, PhD, Sonia Carturan, PhD, Valentina Campia, PhD, Chiara Ghiggi, PhD, Fabio Guolo, PhD, Angelo Michele Carella, MD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Francesco Frassoni, Giuseppe Saglio, MD, Daniela Cilloni, MD
Journal: Blood
Blood (2012) 120 (21): 2500.
https://doi.org/10.1182/blood.V120.21.2500.2500
Published: 2012
Journal Articles

2′–Cyano–2′–Deoxyarabinofuranosylcytosine Is Active in Acute Myeloid Leukaemia and Acts in Synergy with Cytarabine.

Elisabeth J Walsby, Chiara Ghiggi, Ruth H Mackay, Simon R Green, Steven Knapper, Alan K Burnett
Journal: Blood
Blood (2009) 114 (22): 4153.
https://doi.org/10.1182/blood.V114.22.4153.4153
Published: 2009